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Numerous medical disorders, including obstructive sleep apnea, 
may cause nocturnal diaphoresis. Previous work has associ-
ated severe obstructive sleep apnea with nocturnal diaphoresis. 
This case report is of import as our patient with severe nocturnal 
diaphoresis manifested only mild sleep apnea, and, for years, 
his nocturnal diaphoresis was ascribed to other causes, i.e., fi rst 
prostate cancer and then follicular B-cell lymphoma. Additionally, 
it was the nocturnal diaphoresis and not more common symp-
toms of obstructive sleep apnea, such as snoring, that led to the 
defi nitive diagnosis of his sleep apnea and then to treatment with 
a gratifying resolution of his onerous symptom.
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Diverse medical disorders including malignancies, infec-tions, and endocrine abnormalities have been associated 
with nocturnal diaphoresis.1 Nocturnal diaphoresis may occur 
in obstructive sleep apnea syndrome (OSAS).2 Nevertheless, 
research has been limited and fi ndings mixed.3,4 One study 
found night sweats to be associated with snoring and sleepi-
ness but not apnea-hypopnea index (AHI).3 Excessive noctur-
nal sweating occurred in 34% of patients with severe OSAS 
([AHI] = 52).4 Our case is instructive as our patient’s severe 
nocturnal diaphoresis occurred with mild OSAS and was not 
clearly connected to his two malignancies.
REPORT OF CASE
A 67-year-old male fi rst manifested diaphoresis in 2002 fol-
lowing a radical prostatectomy for T2N0MX prostate cancer. 
His clinicians reassured him that diaphoresis, common after 
surgery, should resolve.
It worsened; the patient often soaked through clothing and 
slept on a towel. Endocrine evaluation was negative. A nega-
tive QFT Gold Test for tuberculosis, negative HIV test, normal 
erythrocyte sedimentation rate test (1), and normal testosterone 
level (444) were obtained in 2010. However, follicular B-cell 
lymphoma was diagnosed (1/2011) and thought the likely cause 
of profuse, almost nightly sweats. The Rituximab treatment for 
lymphoma (3/2011) did not improve his diaphoresis. The pa-
tient’s oncologist recommended sleep medicine consultation.
The patient presented 6/2011 to sleep medicine with a chief 
complaint of “severe night sweats that have gotten progressive-
ly worse over the last 12 months.” Sweating was most apparent 
02:30 until 04:00. His registered nurse wife noted infrequent 
snoring and pauses in respiration. He denied restless sleep. Ep-
worth Sleepiness Scale score was normal (5), though he felt 
tired upon arising after 7-8 hours in bed. He used minimal alco-
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hol and no caffeine. He ceased smoking cigarettes in 1975 and 
reported a comfortable bedroom temperature.
Past medical history: Prostate cancer history (treated fi rst 
with surgery, then with radiation therapy in 2006 for micro-
metastatic disease), follicular B-cell lymphoma, radiation cys-
titis, coronary heart disease, supraventricular and ventricular 
dysrhythmias (dronederone previously stopped given concerns 
it contributed to diaphoresis), pacemaker implantation, adeno-
matous colon polyps with dysplasia, pneumonia, previous left 
upper extremity thrombophlebitis, gastroesophageal refl ux 
disease (GERD), Barrett’s esophagus, and distant tonsillec-
tomy history.
Medications (at time of initial sleep center visit) included 
clopidogrel, niacin, atorvastatin, aspirin, fl ecainide, pantopra-
zole, lubiprostone, glucosamine/chondroitin, and fi sh oil. 
Review of systems demonstrated no recent change in weight, 
no history of diabetes mellitus or thyroid disease, and some dif-
fi culties with memory and concentration.
Exam demonstrated a tall, slender male with normal respira-
tory rate and pulse. Upper airway exam revealed no frank ante-
rior septal deviation. He had a large tongue, borderline class III 
malocclusion, Mallampati IV, retrognathia, and 15-inch neck 
circumference. Neck exam revealed normal thyroid, and no 
cervical, supraclavicular, or axillary adenopathy. Cardiopulmo-
nary exam: normal lung sounds and heart tones, and a pace-
maker. There was no cyanosis, clubbing, or edema.
The patient’s diagnostic and continuous positive airway pres-
sure (CPAP) polysomnographic data are presented in Table 1.
By numeric indices, the patient’s diagnostic study manifested 
mild apnea that was more pronounced in stage R sleep. Pre and 
post blood pressures were normal at 109/67 and 104/64, respec-
tively. Esophageal pressure monitoring and ambulatory blood 
pressure monitoring were not done as part of the patient’s clini-
cal evaluation.
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The CPAP titration study revealed control of the patient’s 
apnea and improved oxygen nadir. Blood pressures pre and post 
study, respectively, were again normal at 101/63 and 99/57. In 
neither study was there evidence for other sleep pathology such 
as periodic limb movements of sleep.
The patient began CPAP at 9 cwp. At 1-month follow-up, he 
noted near-disappearance of nocturnal diaphoresis. Diaphoresis 
had taken a few days after CPAP initiation to dissipate. Medi-
cations including niacin remained unchanged. A CPAP down-
load revealed that during the first month (7/12/11-8/10/11), the 
patient used the machine 5 h 45 min per night, with 87% of 
the time ≥ 4 h and with an AHI of 2.9 on 9 cwp. His daily re-
cords for the preceding month indicated no night sweats save 
for “moist” neck area and armpits on 3 nights.
Endocrinology work up (8/2011), requested by the patient’s 
oncologist, revealed normal renal, hepatic, and glucose levels. 
The overall thyroid panel suggested “borderline low” thyroid 
function, yet TSH was normal (2.94).
His last visit (8/2012) revealed continued control of his dia-
phoresis with CPAP therapy. He noted some diaphoresis and 
snoring with CPAP interface slippage.
A CPAP download from 7/8/11-8/1/12 revealed that the pa-
tient used his CPAP machine an average of 5 h 8 min per night, 
with 77% of the time ≥ 4 h and with an AHI of 1.6 on 9 cwp.
At one and a half years post CPAP initiation, on phone com-
munication, the patient believed his diaphoresis was still dra-
matically improved. The patient stated that if he stopped CPAP 
that the first night he would sweat only modestly. With CPAP 
discontinuation for a few days, he noted that increasingly se-
vere diaphoresis ensued.
DISCUSSION
Firstly, this report illustrates the importance of not exclud-
ing OSAS from the differential diagnosis of nocturnal diapho-
resis, despite other more obvious potential etiologies. Secondly, 
this case indicates that even mild OSAS may result in severe 
diaphoresis, extending findings regarding its presence in severe 
OSAS. 4 Thirdly, CPAP both treated mild OSAS and resolved 
the troubling night sweats. This case emphasizes the onerous 
nature of diaphoresis in OSAS, even when unaccompanied by 
more typical symptoms, such as prolific snoring and sleepiness. 
In this case, severe nocturnal diaphoresis was our primary clue 
to the presence of OSAS.
It is possible that the AHI underestimated the patient’s de-
gree of respiratory instability and that the patient may have had 
concomitant respiratory event related arousals (RERAs). How-
ever, a careful review of the raw data did not reveal evidence 
for RERAs. For example, the patient’s breathing was usually in-
phase, and the intercostal electromyogram signals were almost 
exclusively quiet. We did not see subtle out-of-phase breathing 
terminating in arousals. The normal arousal index also argued 
against our missing subtle upper airway events.
Sleep stages have been associated with different predisposi-
tions to diaphoresis. For that reason, we looked for changes in 
stage N3 sleep (the stage with greatest diaphoresis) and stage 
R sleep (the stage ostensibly with the least) that might have 
explained his diaphoresis and response to therapy. We found no 
explanation in our review of the sleep architecture (please see 
minutes of stage R for each study in Table 1. The patient had no 
stage N3 on either study).
We did not analyze heart rate variability (HRV), a measure 
of autonomic function. With only one night in each condition, 
selecting samples for analysis while controlling for proximity 
of apnea events, proximity of arousals, sleep stage, and time of 
night was beyond our capability. 
The severe night sweats in this patient with mild OSAS 
were noteworthy. Few studies3,4 have investigated diaphore-
sis in OSAS. Electrodermal activity has also been utilized to 
probe this relationship in patients with severe apnea (AHI = 
45.3).5 These findings, however, may not be generalizable to 
our patient, who had much milder apnea. Future studies aimed 
at assessing the prevalence of diaphoresis in mild OSAS and 
clarifying its pathophysiological basis may be warranted. Per-
haps this severe diaphoresis reflects individual variability, just 
as some patients with mild OSAS by numeric indices may have 
severe sleepiness. The patient’s sympathetic nervous system 
may have been more sensitive to the impact of OSAS, and the 
sweating may have reflected heightened autonomic activity. 
The association of autonomic dysfunction with mild OSAS was 
previously reported in 2004,6 and, in 2008, systolic non-dipping 
of blood pressure was reported to be associated with sleep ap-
nea, even mild apnea. 7
Finally, this patient had a history of GERD. GERD has itself 
been reported to cause nocturnal sweats,8 to be comorbid with 
OSAS, and improved by CPAP.9 While the improvement of dia-
phoresis by CPAP may have been due to GERD reduction, the 
patient presented to the sleep center with diaphoresis notwith-
standing use of a proton pump inhibitor. Thus, CPAP treatment 
of OSAS was likely primarily responsible for the gratifying re-
sponse described herein.
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